TREPROSTINIL in Pulmonary Hypertension: Evidence and Clinical Trends

Clinical trial NCT07736846 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07736846
Sponsor: AOP Orphan Pharmaceuticals AG
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL

Pulmonary Arterial Hypertension (PAH)

Start date: 2026-07-01
Primary completion: 2029-12-01
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.